article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. That is a key competitive advantage,” says Laursen. “We The impact could be huge for the biopharma industry.

article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improve Your Health, Meet in Person

PM360

The health-conscious among us pay special attention to actively managing our sleep, exercise, vitamins, etc. Biopharma should pay special attention to this. Biopharma companies that bring patients together in-person can create a sense of belonging and support that is often missing in the digital realm. The list goes on.

article thumbnail

Three Sales Compensation Pitfalls to Avoid for a Rare Disease Product Launch

The Marketing Advantage

Lack of Data and/or Proxies There is typically little to no competitive data available With over 95% of the over 7,000 estimated rare diseases having no treatment, these products typically have no competition and thus no competitive data. This, in turn, calls for a more expert and specialized sales force.

Sales 52
article thumbnail

Why Sales Representatives Should Deviate from Call Plans

The Marketing Advantage

We at The Marketing Advantage have been designing call plans based on sales, opportunity, potential, maintenance and growth for the biopharma industry for over 30 years. In fact, in one case, the prescriber was the spouse of a competitive sales representative. Why Don’t Sales Representatives Follow Call Plans?

Sales 40
article thumbnail

Five IDNs to watch in 2023

Clarivate

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.

article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Learn about how AI is helping companies right now, what to know about its benefits and challenges, and what’s needed to implement AI in biopharma research. Companies that combine rapid innovation with speedy but safe trials can gain a multifaceted competitive advantage. How is AI used in the pharmaceutical industry?

Pharma 52